{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:39:56Z","timestamp":1794627596745,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CMU Junior Research Fellowship Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hypertension is a major global health problem that often develops without noticeable symptoms. Current treatments and complementary approaches focus on improving endothelial function and enhancing nitric oxide (NO) production to promote vasodilation and lower blood pressure. Isosakuranetin, a flavanone found in\n                      <jats:italic>Chromolaena odorata<\/jats:italic>\n                      leaves, has shown potential antihypertensive properties. This study aimed to investigate the effects of isosakuranetin on L-N\n                      <jats:sup>G<\/jats:sup>\n                      -Nitroarginine methyl ester (L-NAME)\u2013induced hypertension, focusing on its ability to enhance NO production and reduce oxidative stress.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study investigated the antihypertensive effects of the flavanone isosakuranetin in male Wistar rats (n\u2009=\u20098 per group). Hypertension was induced by L-NAME, a nitric oxide synthase inhibitor, for four weeks, followed by treatment with isosakuranetin (10, 20, or 40\u00a0mg\/kg) or enalapril (10\u00a0mg\/kg) for an additional two weeks. Systolic blood pressure (SBP), heart rate, and body weight were monitored weekly. After six weeks, the effects of isosakuranetin on NO level and oxidative stress were assessed using the Griess reaction, 2\u2019,7\u2019-dichlorofluorescein diacetate (DCF-DA), and superoxide dismutase (SOD) activity assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results demonstrated that the SBP was significantly reduced in the isosakuranetin treatment group when compared to the hypertensive group. Additionally, isosakuranetin treatment significantly restored plasma nitrate\/nitrite levels and showed the potential to reduced oxidative stress, as indicated by the decrease in reactive oxygen species (ROS) levels and a significant increase in SOD activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that isosakuranetin is a promising natural compound for managing hypertension, demonstrating its potential for clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40780-025-00529-z","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:15:20Z","timestamp":1765984520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isosakuranetin ameliorates hypertension in rats induced by L-NAME"],"prefix":"10.1186","volume":"12","author":[{"given":"Rungusa","family":"Pantan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchanaporn","family":"Chokchaisiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichart","family":"Suksamrarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chainarong","family":"Tocharus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"529_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1749-6632.2002.tb04796.x","volume":"977","author":"I Skoog","year":"2002","unstructured":"Skoog I, Gustafson D. Hypertension and related factors in the etiology of alzheimer\u2019s disease. Ann N Y Acad Sci. 2002;977:29\u201336.","journal-title":"Ann N Y Acad Sci"},{"key":"529_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000446082","volume":"42","author":"A Meissner","year":"2016","unstructured":"Meissner A. Hypertension and the brain: a risk factor for more than heart disease. Cerebrovasc Dis. 2016;42:255\u201362.","journal-title":"Cerebrovasc Dis"},{"key":"529_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.26502\/fccm.92920425","volume":"9","author":"MMA Ahmed","year":"2025","unstructured":"Ahmed MMA, Kowayer JSAB, Lootah A, Alhammdi SI, Alshamsi FAS, Almheiri M, et al. The effect of hypertension on cognitive decline and dementia: A Meta-Analysis. Cardiol Cardiovasc Med. 2025;9:65\u201381.","journal-title":"Cardiol Cardiovasc Med"},{"key":"529_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1161\/STROKEAHA.123.046179","volume":"55","author":"SD Singh","year":"2024","unstructured":"Singh SD, Senff JR, van Duijn CM, Rosand J. Treating hypertension: important for heart health, fundamental for brain health. Stroke. 2024;55:1464\u20136.","journal-title":"Stroke"},{"key":"529_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.52711\/2349-2996.2023.00035","volume":"13","author":"A Singh","year":"2023","unstructured":"Singh A, Kumar R, Sharma S. Natural products and hypertension: scope and role in antihypertensive therapy. Asian J Nurs Educ Res. 2023;13:162\u20136.","journal-title":"Asian J Nurs Educ Res"},{"key":"529_CR6","first-page":"1","volume":"13\u20132022","author":"KX Li","year":"2022","unstructured":"Li KX, Wang ZC, Machuki JOA, Li MZ, Wu YJ, Niu MK, et al. Benefits of Curcumin in the vasculature: a therapeutic candidate for vascular remodeling in arterial hypertension and pulmonary arterial hypertension? Front Physiol. 2022;13\u20132022:1\u201324.","journal-title":"Front Physiol"},{"key":"529_CR7","doi-asserted-by":"publisher","first-page":"25579","DOI":"10.1038\/srep25579","volume":"6","author":"Y Yao","year":"2016","unstructured":"Yao Y, Wang W, Li M, Ren H, Chen C, Wang J, et al. Curcumin exerts its anti-hypertensive effect by down-regulating the AT1 receptor in vascular smooth muscle cells. Sci Rep. 2016;6:25579.","journal-title":"Sci Rep"},{"key":"529_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jch.12473","volume":"17","author":"H-P Wang","year":"2015","unstructured":"Wang H-P, Yang J, Qin L-Q, Yang X-J. Effect of Garlic on blood pressure: a meta-analysis. J Clin Hypertens. 2015;17:223\u201331.","journal-title":"J Clin Hypertens"},{"key":"529_CR9","doi-asserted-by":"crossref","unstructured":"Wu R, Zhou Y, Xu H, Zhao W, Zhou L, Zhao Y et al. Aqueous extract of salvia miltiorrhiza bunge reduces blood pressure through inhibiting oxidative stress, inflammation and fibrosis of adventitia in primary hypertension. Front Pharmacol. 2023;14:01\u201314.","DOI":"10.3389\/fphar.2023.1093669"},{"key":"529_CR10","doi-asserted-by":"crossref","unstructured":"Inchan A, Bualeong T, Kaewkong W, Nuengchamnong N, Apaikawee P, Sa-Nguanpong P et al. Antihypertensive effects of Lotus seed (Nelumbo nucifera Gaertn.) extract via eNOS upregulation and oxidative stress reduction in L-NAME-Induced hypertensive rats. Pharmaceuticals (Basel). 2025;18:1\u201316.","DOI":"10.3390\/ph18081156"},{"key":"529_CR11","doi-asserted-by":"publisher","first-page":"1345218","DOI":"10.3389\/fcvm.2024.1345218","volume":"11","author":"R Caminiti","year":"2024","unstructured":"Caminiti R, Carresi C, Mollace R, Macr\u00ec R, Scarano F, Oppedisano F, et al. The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension. Front Cardiovasc Med. 2024;11:1345218.","journal-title":"Front Cardiovasc Med"},{"key":"529_CR12","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00467-022-05802-z","volume":"38","author":"D Dro\u017cd\u017c","year":"2023","unstructured":"Dro\u017cd\u017c D, Dro\u017cd\u017c M, W\u00f3jcik M. Endothelial dysfunction as a factor leading to arterial hypertension. Pediatr Nephrol. 2023;38:2973\u201385.","journal-title":"Pediatr Nephrol"},{"key":"529_CR13","doi-asserted-by":"crossref","unstructured":"Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med. 2022;8:1\u20138.","DOI":"10.3389\/fmed.2021.798958"},{"key":"529_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20184411","volume":"20","author":"A Kr\u00fcger-Genge","year":"2019","unstructured":"Kr\u00fcger-Genge A, Blocki A, Franke R-P, Jung F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20:1\u201322.","journal-title":"Int J Mol Sci"},{"key":"529_CR15","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","volume":"60","author":"CN Marti","year":"2012","unstructured":"Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol. 2012;60:1455\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"529_CR16","doi-asserted-by":"publisher","first-page":"0267","DOI":"10.34133\/bmr.0267","volume":"29","author":"J Sun","year":"2025","unstructured":"Sun J, Wang Z, Sun Y, Zhang J, Zhang F, Tong J, et al. Nitric oxide in Biomaterial-Based therapies for coronary heart disease: mechanistic Insights, current Advances, and translational prospects. Biomaterials Res. 2025;29:0267.","journal-title":"Biomaterials Res"},{"key":"529_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","volume":"109","author":"J Davignon","year":"2004","unstructured":"Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:27\u201332.","journal-title":"Circulation"},{"key":"529_CR18","doi-asserted-by":"publisher","first-page":"812652","DOI":"10.3389\/fcvm.2022.812652","volume":"9","author":"W Li","year":"2022","unstructured":"Li W, Wang Y, Chen S, Zhao J, Su Q, Fan Y, et al. Evaluation of carotid artery atherosclerosis and arterial stiffness in cardiovascular disease risk: an ongoing prospective study from the Kailuan cohort. Front Cardiovasc Med. 2022;9:812652.","journal-title":"Front Cardiovasc Med"},{"key":"529_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4196\/kjpp.2013.17.4.339","volume":"17","author":"JH Sung","year":"2013","unstructured":"Sung JH, Jo YS, Kim SJ, Ryu JS, Kim MC, Ko HJ, et al. Effect of lutein on L-NAME-induced hypertensive rats. Korean J Physiol Pharmacol. 2013;17:339\u201345.","journal-title":"Korean J Physiol Pharmacol"},{"key":"529_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3109\/00365513.2013.828241","volume":"73","author":"V Sozer","year":"2013","unstructured":"Sozer V, Uzun H, Gelisgen R, Kaya M, Kalayci R, Tabak O, et al. The effects of Atorvastatin on oxidative stress in L-NAME-treated rats. Scand J Clin Lab Investig. 2013;73:591\u20137.","journal-title":"Scand J Clin Lab Investig"},{"key":"529_CR21","first-page":"13","volume":"1","author":"AK Al Mouslem","year":"2024","unstructured":"Al Mouslem AK, Almuayli DI, Aldaej SM, Alhaddad ZA, Alhamad FJ, Emeka PM, et al. Attenuation of L-NAME-induced hypertension in rats with elettaria cardamomum\u2013Low-dose amlodipine combination: A possible synergism of covasodilatory effect. Pharmacognosy Magazine. 2024;1:13.","journal-title":"Pharmacognosy Magazine"},{"key":"529_CR22","doi-asserted-by":"publisher","first-page":"8166840","DOI":"10.1155\/2023\/8166840","volume":"2023","author":"MA Razzaq","year":"2023","unstructured":"Razzaq MA, Younis W, Malik MNH, Alsahli TG, Alamgeer, Jahan S, et al. Pulegone prevents hypertension through activation of muscarinic receptors and cyclooxygenase pathway in L-NAME-Induced hypertensive rats. Cardiovasc Ther. 2023;2023:8166840.","journal-title":"Cardiovasc Ther"},{"key":"529_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/360438","volume":"2014","author":"A Ayala","year":"2014","unstructured":"Ayala A, Mu\u00f1oz MF, Arg\u00fcelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev. 2014;2014:1\u201331.","journal-title":"Oxidative Med Cell Longev"},{"key":"529_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/pathophysiology27010007","volume":"27","author":"O Pechanova","year":"2020","unstructured":"Pechanova O, Vrankova S, Cebova M, Chronic L. -Name-Treatment produces hypertension by different mechanisms in peripheral tissues and brain: role of central eNOS. Pathophysiology. 2020;27:46\u201354.","journal-title":"Pathophysiology"},{"key":"529_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126\u201367.","journal-title":"Antioxid Redox Signal"},{"key":"529_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jep.2012.11.023","volume":"145","author":"M Onkaramurthy","year":"2013","unstructured":"Onkaramurthy M, Veerapur V, Thippeswamy B, Reddy TM, Rayappa H, Badami S. Anti-diabetic and anti-cataract effects of Chromolaena odorata Linn., in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2013;145:363\u201372.","journal-title":"J Ethnopharmacol"},{"key":"529_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1248\/bpb.24.1373","volume":"24","author":"T-T Phan","year":"2001","unstructured":"Phan T-T, Wang L, See P, Grayer RJ, Chan S-Y, Lee ST. Phenolic compounds of Chromolaena odorata protect cultured skin cells from oxidative damage: implication for cutaneous wound healing. Biol Pharm Bull. 2001;24:1373\u20139.","journal-title":"Biol Pharm Bull"},{"key":"529_CR28","first-page":"219","volume":"2","author":"VO Bamidele","year":"2008","unstructured":"Bamidele VO, Stephen OO, Kemi D, Bolatito AO, Elizabeth AA, Ayodele OS. Analgesic, anti-inflammatory and antipyretic activities from flavonoid fractions of Chromolaena odorata. J Med Plant Res. 2008;2:219\u201325.","journal-title":"J Med Plant Res"},{"key":"529_CR29","unstructured":"Ukpai O, Amaechi E. Evaluation of in vivo antimalarial activity of the ethanolic leaf extracts of Chromolaena odorata and cymbopogon citratus in mice. Niger J Biotechnol. 2012;24."},{"key":"529_CR30","doi-asserted-by":"crossref","unstructured":"de Oliveira JAM, Bernardi DI, Balbinot RB, da Silva Av\u00edncola A, Pilau E, do, Carmo MRB et al. Chemotaxonomic value of flavonoids in Chromolaena congesta (Asteraceae). Biochem Syst Ecol. 2017;70:7\u201313.","DOI":"10.1016\/j.bse.2016.10.013"},{"key":"529_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1248\/cpb.59.129","volume":"59","author":"TM Hung","year":"2011","unstructured":"Hung TM, Cuong TD, Dang NH, Zhu S, Long PQ, Komatsu K, et al. Flavonoid glycosides from Chromolaena odorata leaves and their in vitro cytotoxic activity. Chem Pharm Bull. 2011;59:129\u201331.","journal-title":"Chem Pharm Bull"},{"key":"529_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/14786410600899050","volume":"20","author":"N Pisutthanan","year":"2006","unstructured":"Pisutthanan N, Liawruangrath B, Liawruangrath S, Bremner JB. A new flavonoid from Chromolaena odorata. Nat Prod Res. 2006;20:1192\u20138.","journal-title":"Nat Prod Res"},{"key":"529_CR33","doi-asserted-by":"publisher","first-page":"1453612","DOI":"10.1155\/2019\/1453612","volume":"2019","author":"DA Putri","year":"2019","unstructured":"Putri DA, Fatmawati S. A new Flavanone as a potent antioxidant isolated from Chromolaena odorata L. leaves. Evid-based Complement Altern Med. 2019;2019:1453612.","journal-title":"Evid-based Complement Altern Med"},{"key":"529_CR34","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1248\/bpb.32.1244","volume":"32","author":"H Maruyama","year":"2009","unstructured":"Maruyama H, Sumitou Y, Sakamoto T, Araki Y, Hara H. Antihypertensive effects of flavonoids isolated from Brazilian green propolis in spontaneously hypertensive rats. Biol Pharm Bull. 2009;32:1244\u201350.","journal-title":"Biol Pharm Bull"},{"key":"529_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1080\/07391102.2023.2205940","volume":"42","author":"A Janyou","year":"2024","unstructured":"Janyou A, Moohammadaree A, Jumnongprakhon P, Tocharus C, Chokchaisiri R, Suksamrarn A, et al. Effects of Isosakuranetin on cerebral infarction and blood brain barrier damage from cerebral ischemia\/reperfusion injury in a rat model. J Biomol Struct Dyn. 2024;42:1064\u201371.","journal-title":"J Biomol Struct Dyn"},{"key":"529_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF02980123","volume":"27","author":"A Suksamrarn","year":"2004","unstructured":"Suksamrarn A, Chotipong A, Suavansri T, Boongird S, Timsuksai P, Vimuttipong S, et al. Antimycobacterial activity and cytotoxicity of flavonoids from the flowers of Chromolaena odorata. Arch Pharmacal Res. 2004;27:507\u201311.","journal-title":"Arch Pharmacal Res"},{"key":"529_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1874192401004010302","volume":"4","author":"A Sandoo","year":"2010","unstructured":"Sandoo A, van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010;4:302\u201312.","journal-title":"Open Cardiovasc Med J"},{"key":"529_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/hr.2011.39","volume":"34","author":"E Schulz","year":"2011","unstructured":"Schulz E, Gori T, M\u00fcnzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34:665\u201373.","journal-title":"Hypertens Res"},{"key":"529_CR39","first-page":"1","volume":"8\u20132021","author":"G Gallo","year":"2022","unstructured":"Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med. 2022;8\u20132021:1\u20138.","journal-title":"Front Med"},{"key":"529_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/hr.2012.138","volume":"35","author":"Y Higashi","year":"2012","unstructured":"Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35:1039\u201347.","journal-title":"Hypertens Res"},{"key":"529_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.123.22329","volume":"81","author":"DG Harrison","year":"2024","unstructured":"Harrison DG, Bader M, Lerman LO, Fink G, Karumanchi SA, Reckelhoff JF, et al. Tail-Cuff versus radiotelemetry to measure blood pressure in mice and rats. Hypertension. 2024;81:3\u20135.","journal-title":"Hypertension"},{"key":"529_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2147\/JEP.S319787","volume":"13","author":"L Belemnaba","year":"2021","unstructured":"Belemnaba L, Niti\u00e9ma M, Ilboudo S, Ou\u00e9draogo GG, Ou\u00e9draogo N, Belemlilga MB, et al. Preclinical evaluation of the antihypertensive effect of an aqueous extract of anogeissus Leiocarpa (DC) Guill et Perr. Bark of trunk in L-NAME-Induced hypertensive rat. J Exp Pharmacol. 2021;13:739\u201354.","journal-title":"J Exp Pharmacol"},{"key":"529_CR43","doi-asserted-by":"publisher","first-page":"6633825","DOI":"10.1155\/2021\/6633825","volume":"2021","author":"JY Kim","year":"2021","unstructured":"Kim JY, Lee E, Koo S, Kim CW, Kim I. Transfer of Th17 from adult spontaneous hypertensive rats accelerates development of hypertension in juvenile spontaneous hypertensive rats. Biomed Res Int. 2021;2021:6633825.","journal-title":"Biomed Res Int"},{"key":"529_CR44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1291\/hypres.31.793","volume":"31","author":"L Paulis","year":"2008","unstructured":"Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, et al. Regression of L-NAME\u2013Induced hypertension: the role of nitric oxide and Endothelium-Derived constricting factor. Hypertens Res. 2008;31:793\u2013803.","journal-title":"Hypertens Res"},{"key":"529_CR45","doi-asserted-by":"crossref","unstructured":"De Moudt S, Hendrickx JO, Neutel C, De Munck D, Leloup A, De Meyer GRY et al. Aortic stiffness in L-NAME treated C57Bl\/6 mice displays a shift from early endothelial dysfunction to late-term vascular smooth muscle cell dysfunction. Front Physiol. 2022;13:1\u201316.","DOI":"10.3389\/fphys.2022.874015"},{"key":"529_CR46","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","volume":"128","author":"KK Griendling","year":"2021","unstructured":"Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res. 2021;128:993\u20131020.","journal-title":"Circ Res"},{"key":"529_CR47","first-page":"01","volume":"14","author":"RL Li","year":"2023","unstructured":"Li RL, Wang LY, Duan HX, Qian D, Zhang Q, He LS, et al. Natural flavonoids derived from herbal medicines are potential anti-atherogenic agents by inhibiting oxidative stress in endothelial cells. Front Pharmacol. 2023;14:01\u201315.","journal-title":"Front Pharmacol"},{"key":"529_CR48","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1590\/0001-3765201720160509","volume":"89","author":"B Monsalve","year":"2017","unstructured":"Monsalve B, Concha-Meyer A, Palomo I, Fuentes E. Mechanisms of endothelial protection by natural bioactive compounds from fruit and vegetables. Acad Bras Cienc. 2017;89:615\u201333.","journal-title":"Acad Bras Cienc"},{"key":"529_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1024\/0301-1526\/a000971","volume":"50","author":"K Li","year":"2021","unstructured":"Li K, Zemmrich C, Bramlage P, Persson AB, Sacirovic M, Ritter O, et al. Effect of ACEI and ARB treatment on nitric oxide-dependent endothelial function. Vasa. 2021;50:413\u201322.","journal-title":"Vasa"},{"key":"529_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.33549\/physiolres.931396","volume":"56","author":"O Pech\u00e1\u0148ov\u00e1","year":"2007","unstructured":"Pech\u00e1\u0148ov\u00e1 O. Contribution of Captopril thiol group to the prevention of spontaneous hypertension. Physiol Res. 2007;56:41\u20138.","journal-title":"Physiol Res"},{"key":"529_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","volume":"86","author":"KK Griendling","year":"2000","unstructured":"Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494\u2013501.","journal-title":"Circ Res"},{"key":"529_CR52","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315\u2013424.","journal-title":"Physiol Rev"},{"key":"529_CR53","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","volume":"113","author":"U Forstermann","year":"2006","unstructured":"Forstermann U, M\u00fcnzel T. Endothelial nitric oxide synthase in vascular disease: from Marvel to menace. Circulation. 2006;113:1708\u201314.","journal-title":"Circulation"},{"key":"529_CR54","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1089\/ars.2005.7.1302","volume":"7","author":"RM Touyz","year":"2005","unstructured":"Touyz RM. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal. 2005;7:1302\u201314.","journal-title":"Antioxid Redox Signal"},{"key":"529_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/01.RES.0000258450.44413.96","volume":"100","author":"NR Madamanchi","year":"2007","unstructured":"Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007;100:460\u201373.","journal-title":"Circ Res"},{"key":"529_CR56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","volume":"237","author":"H Li","year":"2014","unstructured":"Li H, Horke S, F\u00f6rstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237:208\u201319.","journal-title":"Atherosclerosis"},{"key":"529_CR57","first-page":"1","volume":"8\u20132017","author":"Y Luo","year":"2017","unstructured":"Luo Y, Shang P, Li D. Luteolin: a flavonoid that has multiple cardio-protective effects and its molecular mechanism. Front Pharmacol. 2017;8\u20132017:1\u201310.","journal-title":"Front Pharmacol"},{"key":"529_CR58","first-page":"1","volume":"10","author":"Y Liu","year":"2024","unstructured":"Liu Y, Luo J, Peng L, Zhang Q, Rong X, Luo Y, et al. Flavonoids: potential therapeutic agents for cardiovascular disease. Heliyon. 2024;10:1\u201315.","journal-title":"Heliyon"},{"key":"529_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2006.07.021","volume":"547","author":"M Bao","year":"2006","unstructured":"Bao M, Lou Y. Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPK. Eur J Pharmacol. 2006;547:22\u201330.","journal-title":"Eur J Pharmacol"},{"key":"529_CR60","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","volume":"4","author":"MP Murphy","year":"2022","unstructured":"Murphy MP, Bayir H, Belousov V, Chang CJ, Davies KJA, Davies MJ, et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metabolism. 2022;4:651\u201362.","journal-title":"Nat Metabolism"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00529-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-025-00529-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00529-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:04:01Z","timestamp":1768997041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40780-025-00529-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1186\/s40780-025-00529-z","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval for animal research under the reference number 02\/2562 before its commencement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}